KOSE Holdings Corporation (TYO:4922)
Japan
· Delayed Price · Currency is JPY 5,694.00
-68.00 (-1.18%)
At close: Mar 9, 2026
KOSE Holdings Revenue
In the year 2025, KOSE Holdings had annual revenue of 330.19B JPY with 2.30% growth. KOSE Holdings had revenue of 89.68B in the quarter ending December 31, 2025, with 6.72% growth.
Revenue
330.19B
Revenue Growth
+2.30%
P/S Ratio
0.98
Revenue / Employee
40.61M
Employees
8,130
Market Cap
324.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 330.19B | 7.44B | 2.30% |
| Dec 31, 2024 | 322.76B | 22.35B | 7.44% |
| Dec 31, 2023 | 300.41B | 11.27B | 3.90% |
| Dec 31, 2022 | 289.14B | -11.10B | -3.70% |
| Dec 31, 2021 | 300.24B | 20.85B | 7.46% |
| Mar 31, 2021 | Pro | Pro | Pro |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pola Orbis Holdings | 170.29B |
| Paltac | 1,227.67B |
| Kobayashi Pharmaceutical | 165.74B |
| MTG Co., Ltd. | 109.56B |
| Lion Corporation | 422.09B |
| Rohto Pharmaceutical | 335.80B |
| Pigeon | 109.17B |
| Noevir Holdings | 63.39B |